Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-01

FDA Approved: AZACITIDINE — Supplemental Application (Panacea Biotec Limited)

View source ↗

Summary

FDA approved a supplemental application for azacitidine from Panacea Biotec Limited, allowing the generic azacitidine product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)

Snippet

SUPPL AP for AZACITIDINE (AZACITIDINE)